The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey

6Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Since the beginning of the COVID-19 pandemic, there has been an overall improvement in patient mortality. However, haematological malignancy patients continue to experience significant impacts from COVID-19, including high rates of hospitalization, intensive care unit (ICU) admissions, and mortality. In comparison to other haematological malignancy patients, individuals with chronic myeloid leukemia (CML) generally have better prognosis. This study, conducted using a large haematological malignancy patient database (EPICOVIDEHA), demonstrated that the majority of CML patients experienced mild infections. The decline in severe and critical infections over the years can largely be attributed to the widespread administration of vaccinations and the positive response they elicited. Notably, the mortality rate among CML patients was low and exhibited a downward trend in subsequent years. Importantly, our analysis provided confirmation of the effectiveness of vaccinations in CML patients.

References Powered by Scopus

A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

3605Citations
N/AReaders
Get full text

Long-term outcomes of imatinib treatment for chronic myeloid leukemia

966Citations
N/AReaders
Get full text

Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population

679Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

9Citations
N/AReaders
Get full text

Risk of SARS-CoV-2 infection and severe COVID-19 in hematological patients who received or not pre-exposure prophylaxis with tixagevimab/cilgavimab: a target trial emulation

1Citations
N/AReaders
Get full text

Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: EPICOVIDEHA-EPIFLUEHA Report

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

El-Ashwah, S., Salmanton-García, J., Bilgin, Y. M., Itri, F., Žák, P., Weinbergerová, B., … Pagano, L. (2024). The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey. Leukemia and Lymphoma, 65(2), 199–208. https://doi.org/10.1080/10428194.2023.2280886

Readers over time

‘2402468

Readers' Seniority

Tooltip

Lecturer / Post doc 1

100%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 1

50%

Veterinary Science and Veterinary Medic... 1

50%

Save time finding and organizing research with Mendeley

Sign up for free
0